Obesity: An Addiction? Imaging of Neurotransmitter Systems in Obesity

Autor: van de Giessen, Elsmarieke, McIlwrick, Silja, Veltman, Dick, van den Brink, Wim, Booij, Jan, Dierckx, Rudy A. J. O., Otte, Andreas, de Vries, Erik F. J., van Waarde, Aren, den Boer, Johan A.
Přispěvatelé: Radiology and nuclear medicine, Anatomy and neurosciences, Psychiatry, Amsterdam Neuroscience - Brain Imaging, Amsterdam Neuroscience - Mood, Anxiety, Psychosis, Stress & Sleep, Nuclear Medicine, Other departments, Amsterdam Neuroscience, Adult Psychiatry, Radiology and Nuclear Medicine, ANS - Brain Imaging, ANS - Compulsivity, Impulsivity & Attention
Rok vydání: 2020
Předmět:
Zdroj: PET and SPECT in Psychiatry ISBN: 9783030572303
PET and SPECT in Psychiatry: Second Edition, 841-860
STARTPAGE=841;ENDPAGE=860;TITLE=PET and SPECT in Psychiatry: Second Edition
van de Giessen, E, McIlwrick, S, Veltman, D, van den Brink, W & Booij, J 2020, Obesity : An addiction? Imaging of neurotransmitter systems in obesity . in PET and SPECT in Psychiatry: Second Edition . PET and SPECT in Psychiatry: Second Edition, Springer International Publishing, pp. 841-860 . https://doi.org/10.1007/978-3-030-57231-0_26
PET and SPECT in Psychiatry ISBN: 9783642403835
PET and SPECT in psychiatry, 641-656
STARTPAGE=641;ENDPAGE=656;TITLE=PET and SPECT in psychiatry
Popis: The brain is important in the regulation of eating behavior and satiety signaling. There is also evidence that many neurotransmitters are involved in food intake regulation and eating behavior; consequently dysregulated neurotransmitter systems may be involved in the pathophysiology of obesity. This chapter presents an overview of results of neurotransmitter imaging studies in obese humans. Presently, the dopaminergic, serotonergic, noradrenergic, opioid and cannabinoid systems have been studied with molecular imaging techniques in obese humans. The major findings are increased serotonin (5-hydroxytryptamine; 5-HT) 5-HT2A receptor availability in cortical regions, a complex relationship between dopamine D2/3 receptor (DRD2/3) availability and body mass index (BMI), probably an important role of the striatal and extra-striatal mu opioid receptor, and a possible role of the cannabinoid type 1 (CB1) receptor. There is no disturbance in serotonin transporter (SERT) availability in the thalamus and midbrain or in striatal dopamine transporter (DAT) availability. The effects of bariatric surgery on neurotransmission and findings in subgroups such as patients with binge eating disorder or insulin resistance are also discussed.
Databáze: OpenAIRE